FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers

FDA proposes adding warnings on labeling for OTC pain relievers to advise consumers of "potential health risks" associated with acetaminophen and NSAIDs such as aspirin, ibuprofen and naproxen